These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 9800666)

  • 1. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses.
    Sarrel P; Dobay B; Wiita B
    J Reprod Med; 1998 Oct; 43(10):847-56. PubMed ID: 9800666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefits of androgens combined with hormone replacement therapy regarding to patients with postmenopausal sexual symptoms.
    de Paula FJ; Soares JM; Haidar MA; de Lima GR; Baracat EC
    Maturitas; 2007 Jan; 56(1):69-77. PubMed ID: 16822626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women.
    Warnock JK; Swanson SG; Borel RW; Zipfel LM; Brennan JJ;
    Menopause; 2005; 12(4):374-84. PubMed ID: 16037752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
    Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
    J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal women.
    Penteado SR; Fonseca AM; Bagnoli VR; Abdo CH; Júnior JM; Baracat EC
    Climacteric; 2008 Feb; 11(1):17-25. PubMed ID: 18202961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire.
    Lobo RA; Rosen RC; Yang HM; Block B; Van Der Hoop RG
    Fertil Steril; 2003 Jun; 79(6):1341-52. PubMed ID: 12798881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of low-dose conjugated estrogens on sexual function and quality of life in postmenopausal women.
    Gast MJ; Freedman MA; Vieweg AJ; De Melo NR; Girão MJ; Zinaman MJ;
    Menopause; 2009; 16(2):247-56. PubMed ID: 19034054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of esterified estrogens with and without methyltestosterone: effects on endometrial histology and serum lipoproteins in postmenopausal women.
    Hickok LR; Toomey C; Speroff L
    Obstet Gynecol; 1993 Dec; 82(6):919-24. PubMed ID: 8233265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
    Slater CC; Zhang C; Hodis HN; Mack WJ; Boostanfar R; Shoupe D; Paulson RJ; Stanczyk FZ
    J Reprod Med; 2001 Dec; 46(12):1052-6. PubMed ID: 11789085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
    Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
    Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.